The efficacy and safety of perioperative blood glucose management using artificial pancreas in patients with hepato-pancreato-biliary surgery

The efficacy and safety of perioperative blood glucose management using artificial pancreas in patients with hepato-pancreato-biliary surgery - The efficacy and safety of perioperative blood glucose management using artificial pancreas

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023460

Enrollment

Registered

2016-08-05

Start date

2016-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatectomy above 1 sector Pancreatoduodenectomy Distal pancreatectomy

Interventions

Treatment Group (Target blood glucose range is from 80 to 110 mg/dl) Control Group (Target blood glucose range is from 80 to 180 mg/dl)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients received following surgery a) Hepatectomy above 1 sector b) Pancreatoduodenectomy c) Distal pancreatectomy 2) ECOG Performance Status Scale: 0-1 3) Patients with impaired glucose tolerance 4) Age between 20 y.o. to 85 y.o.

Exclusion criteria

Exclusion criteria: 1)Patients with severe respiratory disease 2)Dialysis patients with chronic renal failure 3)Other inadequate case judged by study participated doctor

Design outcomes

Primary

Measure	Time frame
The incidence of postoperative complications	—

Secondary

Measure	Time frame
1) Perioperative blood glucose values, glycemic variability 2) Postoperative hospital days 3) inflammation-related factors	—

Countries

Japan

Contacts

Public ContactHiroya Akabori

Shiga University of Medical Science Department of Surgery

hakabori@belle.shiga-med.ac.jp077-548-2238

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026